The practicing physician served as the medical director of the Memorial Sloan Kettering Cancer Center in New York from 2013 to 2018, and led AstraZeneca’s oncology research and development in 2019. As the head of oncology at the Vall d’Hebron Hospital, he founded VHIO, one of the most powerful cancer research centers in the country.
Barcelona Oncologist Josep BaselgaHe is a leader in the fight against breast cancer, a pioneer in personalized therapy, and has served as the global director of oncology research and development for AstraZeneca Pharmaceuticals since 2019. He died of the disease yesterday at the age of 61. Creutzfeldt-Jakobs, This is a rare and rapidly developing neurodegenerative disease.
Born in 1959, Baselga served as the medical director of the Memorial Sloan Kettering Cancer Center in New York from 2013 to 2018 and served as the director of oncology at the hospital. Val d Hebro HospitalHeld in Barcelona from 1996 to 2010. Vall d’Hebron Cancer Institute (VHIO), has become a reference for cancer research in Spain. In 2010, he moved to Boston and served as the head of the oncology department at the Massachusetts General Hospital and integrated with the scientific activities of the Barcelona Hospital.
The phrase that is always associated with the oncologist is his motto: “Research progress must be delivered to patients as soon as possible.” Unlike chemotherapy and radiotherapy, molecular cancer therapy that targets tumors precisely and selectively is his big bet.He spends most of his research work on understanding how cancer cell And look for their weaknesses.
Regarding SEOM, we regret the death of Dr. Baselga. Dr. Baselga is a reference in oncology, the initiator of personalized therapy, and is committed to ensuring that research progress is delivered to patients as soon as possible. Hug family and friends. DEPhttps://t.co/s9dOmfH5mi
-SEOM (@_SEOM) March 21, 2021
In multiple Recognized The award won the 28th Catalonia International Award in 2016, the Barcelona Medal of Honor in 2012, the King Jaime I of Medical Research in 2008 and the Minister of Health Medal in 2008.
In 2018 New York Times published Reportage Next to the research platform PSAs The information it gathers is that Bank of Baselga has omitted the financial connections of dozens of research articles in scientific publications. This conflict of interest caused the oncologist to leave the medical guidance of the Sloan Kettering Cancer Center.
After publishing this information, the doctor promised to correct his conflict of interest reports published in journals such as Science in 17 articles. New England Journal of Medicine Ø Lancet.